-
-
Prevention of ventilator associated pneumonia (VAP) is a key area of focus for promoting quality of care in the intensive care unit (ICU) and best patient outcomes.
-
In addition to their cholesterol-lowering properties, hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, commonly referred to as statins, have been shown to modify inflammatory and immunologic pathways.
-
Headaches are one of the most common problems of patients presenting to primary care physicians. Workup and management can be both frustrating and demanding.
-
-
-
Depression and pregnancy, new vaccine recommendations from the CDC, cortico-steroids and/or antivirals for Bell's palsy, rasagiline and Parkinson's disease, and FDA Actions.
-
-
Oseltamivir (Tamiflu®) is an FDA-approved drug for the treatment and prevention of influenza. With the anticipated emergence of seasonal influenza virus cases in October, and the recent discoveries of novel H5N1 (avian) and 2009 H1N1 (swine) influenza viruses, it is imperative to understand how to appropriately dose oseltamivir.
-
Dual antiplatelet therapy with aspirin and clopidogrel has become the standard of care for patients suffering an acute coronary syndrome (ACS). However, there remains a significant incidence of recurrent ACS and mortality even in patients treated with dual antiplatelet therapy. Furthermore, clopidogrel is an irreversible platelet inhibitor, and patients requiring urgent surgery are at higher risk of bleeding if operated on within 5-7 days of clopidogrel use.